Filing Details
- Accession Number:
- 0001061983-20-000075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-06 18:39:12
- Reporting Period:
- 2020-05-05
- Accepted Time:
- 2020-05-06 18:39:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061983 | Cytokinetics Inc | CYTK | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1013419 | J Santo Costa | 280 East Grand Avenue South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-05 | 4,166 | $6.78 | 4,166 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-05 | 4,166 | $17.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-05-05 | 4,166 | $5.46 | 4,166 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-05 | 4,166 | $17.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-05 | 4,166 | $17.00 | 4,166 | $5.46 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-05 | 4,166 | $17.00 | 4,166 | $6.78 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-06-22 | 2022-05-22 | No | 4 | M | Direct |
0 | 2013-06-22 | 2023-05-22 | No | 4 | M | Direct |